TB vaccine remodels brain immune system to potentially lower Alzheimer's risk: Harvard study says

Image for TB vaccine remodels brain immune system to potentially lower Alzheimer's risk: Harvard study says

A vaccine given to babies… might be quietly protecting old brains too.

Sounds like a stretch.

It isn't.

Harvard just found the receipts.

For over a century, the BCG vaccine has done one job: guard kids against tuberculosis.

A tiny scar on the arm. That's usually the last you think about it.

But scientists kept noticing something strange.

People who got BCG later in life — for bladder cancer treatment, of all things — seemed to develop Alzheimer's less often.

One earlier study clocked it at nearly 20% lower risk.

Coincidence? That's what everyone assumed. Until now.


🧠 So what did Harvard actually do?

Researchers pulled in 23 adults, all 55 or older.

  • 12 with no signs of Alzheimer's pathology

  • 11 already showing early physical changes in the brain

Everyone got the BCG shot.

Then, for a full year, scientists tracked their blood and the fluid bathing their brain and spinal cord.

They weren't looking for TB antibodies.

They were watching amyloid-beta — the sticky protein clumps that define Alzheimer's.


🤯 The twist nobody expected

In the healthy group, something shifted.

👉 Amyloid-beta dropped significantly in the brain and spinal fluid.

👉 It rose in the bloodstream.

Read that again.

It looks like the brain was clearing out the very protein linked to Alzheimer's — and pushing it out into the blood.

But here's the catch.

In participants who already had Alzheimer's-related brain changes?

Nothing moved.

The vaccine simply didn't shift their biomarkers at all.


⚡ Why this actually matters

BCG isn't just a vaccine anymore, scientists say.

It's a masterclass in "trained immunity" — where immune cells get reprogrammed and stay altered for months, sometimes years.

That reprogramming, it turns out, may ripple all the way into brain health.

Timing looks like everything here.

Get the immune boost early, before damage sets in, and the brain's cleanup crew might actually respond.

Wait too long, and the door may already be shut.


🎯 The honest catch

This was 23 people. Not 23,000.

No control group getting a placebo.

Lead researchers themselves are calling for bigger, randomized trials before anyone starts talking prevention or treatment.

But for a 100-year-old TB shot to even be in this conversation…

That's not nothing.

That's a century-old vaccine possibly getting a second job.

That's all for now!